Fidelity Investments’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-83
| Closed | -$330 | – | 5453 |
|
|
2025
Q3 | $330 | Buy |
+83
| New | +$565 | ﹤0.01% | 5119 |
|
|
2023
Q3 | – | Sell |
-129
| Closed | -$2.17K | – | 5307 |
|
|
2023
Q2 | $2.17K | Sell |
129
-548
| -81% | -$9.43K | ﹤0.01% | 4567 |
|
|
2023
Q1 | $10.6K | Buy |
677
+524
| +342% | +$10.2K | ﹤0.01% | 4107 |
|
|
2022
Q4 | $2.57K | Buy |
153
+80
| +110% | +$1.44K | ﹤0.01% | 4451 |
|
|
2022
Q3 | $1K | Buy |
+73
| New | +$1.6K | ﹤0.01% | 4638 |
|
|
2022
Q1 | – | Sell |
-8
| Closed | – | – | 5007 |
|
|
2021
Q4 | $0 | Sell |
8
-1
| -11% | -$65 | ﹤0.01% | 4393 |
|
|
2021
Q3 | $1K | Buy |
+9
| New | +$794 | ﹤0.01% | 4107 |
|
|
2019
Q1 | – | Sell |
-55
| Closed | -$1K | – | 3659 |
|
|
2018
Q4 | $1K | Sell |
55
-11,720
| -100% | -$550K | ﹤0.01% | 3381 |
|
|
2018
Q3 | $1.09M | Sell |
11,775
-5,619
| -32% | -$668K | ﹤0.01% | 2466 |
|
|
2018
Q2 | $2.79M | Sell |
17,394
-6,612
| -28% | -$1.11M | ﹤0.01% | 2282 |
|
|
2018
Q1 | $3.86M | Sell |
24,006
-11,624
| -33% | -$1.42M | ﹤0.01% | 2243 |
|
|
2017
Q4 | $3.74M | Sell |
35,630
-29,783
| -46% | -$3.2M | ﹤0.01% | 2231 |
|
|
2017
Q3 | $8.58M | Sell |
65,413
-6
| -0% | -$733 | ﹤0.01% | 1996 |
|
|
2017
Q2 | $8.94M | Buy |
65,419
+6,146
| +10% | +$738K | ﹤0.01% | 1981 |
|
|
2017
Q1 | $7.06M | Sell |
59,273
-9,367
| -14% | -$1.11M | ﹤0.01% | 2081 |
|
|
2016
Q4 | $9.21M | Buy |
68,640
+54,259
| +377% | +$13.6M | ﹤0.01% | 2003 |
|
|
2016
Q3 | $3.74M | Buy |
+14,381
| New | +$1.76M | ﹤0.01% | 2256 |
|
Other funds holding CLSD
Fidelity Investments's CLSD Position: Q4 2025 in Review
Fidelity Investments sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 83 shares — an estimated $330 sold.
Fidelity Investments first reported a position in CLSD in Q3 2016 and held it in 17 quarters. The position peaked at $9.21M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- Fidelity Investments reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- Fidelity Investments sold 83 Clearside Biomedical shares in Q4 2025, an estimated $330.
- Fidelity Investments first reported a position in Clearside Biomedical in Q3 2016 and held it in 17 quarters.
- Fidelity Investments's Clearside Biomedical position peaked at $9.21M in Q4 2016.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.